Trial intelligence / Profile preview

S-1 and Avastin in KRAS-mutated colorectal cancer

NCT00974389Phase 2Unknown

Sponsor
Osaka Medical and Pharmaceutical University
Start
Jul 2009
Primary completion
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tegafur in colorectal cancer (CRC), sponsored by Osaka Medical and Pharmaceutical University. Status: unknown.

02

Drugs

tegafur
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00974389.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00974389.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call